Abstract
Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Current Signal Transduction Therapy
Title:Current Biomarkers for Lung Cancer
Volume: 9 Issue: 3
Author(s): Kaifei Wang, Zhaohui Huang, Ruilin Wang, Jin Qian, Zhenhua Zuo, Yaping Li, Xiaoyan Yao and Xizhou Guan
Affiliation:
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Abstract: Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Export Options
About this article
Cite this article as:
Wang Kaifei, Huang Zhaohui, Wang Ruilin, Qian Jin, Zuo Zhenhua, Li Yaping, Yao Xiaoyan and Guan Xizhou, Current Biomarkers for Lung Cancer, Current Signal Transduction Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574362409666140911225531
DOI https://dx.doi.org/10.2174/1574362409666140911225531 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery The Application of Proteomics for the Early Detection of Lung Cancer
Current Proteomics microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Molecular Mechanisms of Liver Cancer
Anti-Cancer Agents in Medicinal Chemistry Nanosuspensions of Poorly Water Soluble Drugs Prepared by Top-down Technologies
Current Pharmaceutical Design Regulation of Mitochondrial Function and its Impact in Metabolic Stress
Current Medicinal Chemistry Characterization of Stem-Like Cells Directly Isolated from Freshly Resected Laryngeal Squamous Cell Carcinoma Specimens
Current Stem Cell Research & Therapy Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems
Current Drug Targets TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Current Pharmaceutical Biotechnology Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design OX40 and OX40L Interaction in Cancer
Current Medicinal Chemistry Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets A New Era of Immunotherapy in Prostate Cancer
Current Molecular Pharmacology Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Current Medicinal Chemistry Enediyne Anticancer Antibiotic Lidamycin: Chemistry, Biology and Pharmacology
Anti-Cancer Agents in Medicinal Chemistry Identification of HIV Inhibitors Guided by Free Energy Perturbation Calculations
Current Pharmaceutical Design Advances in Tumor Targeted Liposomes
Current Molecular Medicine Development Course and an Application Strategy for Induced Pluripotent Stem Cells in Regenerative Medicine
Current Stem Cell Research & Therapy Features Identification for Phenotypic Classification Based on Genes and Gene Pairs
Current Bioinformatics Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Current Molecular Medicine